People who get health insurance through their jobs pay more than twice as much for insulin at the beginning of the year than they do at the end of the year, on average. New analysis of HCCI data shows that, nationally, in January 2017, average out-of-pocket spending on insulin was $105. This spending declined every month throughout the calendar year, likely as enrollees met their annual deductible...
HCCI research on shoppable services was mentioned in an article written by the LA Times. From the article: "By one estimate by the Health Care Cost Institute, just 7% of total healthcare spending for Americans with job-based coverage was on medical services that could be considered 'shoppable' because the service required an out-of-pocket payment and the procedure could be researche...
HCCI's research on median in-network rates was recently featured in a Health Affairs blog post on surprise billing. From the blog: "Most importantly, Congress should establish a locally based benchmark to determine the amount an insurer would be required to pay a provider for a surprise bill. Ideally, we'd set the benchmark at some multiple (for example 125 percent) of what Medicare pays to ...
HCCI's research on insulin prices was mentioned in a CNBC report. From the article: "The Centers for Disease Control and Prevention estimates more than 30 million Americans have diabetes. The annual cost of insulin for people with Type 1 diabetes in the U.S. nearly doubled from 2012 to 2016 to $5,700 from $2,900, according to an analysis by the nonprofit Health Care Cost Institute. Eli L...
HCCI recently provided cost information for iron infusions for an NPR article. From the article: "An analysis of private insurance claims conducted by the Health Care Cost Institute, an independent research group funded by insurers, found that in 2017, private health plans paid $4,316 per visit, on average, if a patient received Injectafer infusions. Feraheme, the next most expensive in...
